After completing this activity, pharmacists should be able to:
- Describe the features and prevalence of influenza, and patient groups most at risk of severe illness
- Differentiate the symptoms of influenza from those of other acute respiratory diseases, including COVID-19
- Identify the 2020 influenza vaccines and their recommended use in different patient groups
- Explain the role of the pharmacist in influenza vaccination and supporting patients with the illness.
Competency standards addressed (2016): 1.3, 2.2, 3.1, 3.2, 3.3, 3.5, 3.6.
Accreditation number: A2007ITK1 Accreditation expires:30/06/2022
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.